Neurokinin 1 receptor signaling mediates sex differences in μ and κ opioid-induced enhancement of contact hypersensitivity

Journal of Neuroimmunology

Volumn 181, Issue 1-2, 2006, Pages 100-105

  Elliott, Jay C ^a   Wagner, Alison F ^a   Lysle, Donald T ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Contact hypersensitivity; Opioid; Sex difference; Substance P

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NOLPITANTIUM; SAREDUTANT; SPIRADOLINE MESILATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNOMODULATION; MALE; NEUROIMMUNOLOGY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKIN INFLAMMATION;

ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; DERMATITIS, CONTACT; DRUG INTERACTIONS; FEMALE; MALE; MORPHINE; PIPERIDINES; PYRROLIDINES; QUINUCLIDINES; RATS; RATS, INBRED F344; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SUBSTANCE P;

EID: 36248983344     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.08.011     Document Type: Article

References (32)

1. Amann R., Schuligoi R., Holzer P., and Donnerer J. The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 352 (1995) 201-205
2. Belvisi M.G., Rogers D.F., and Barnes P.J. Neurogenic plasma extravasation: inhibition by morphine in guinea pig airways in vivo. J. Appl. Physiol. 66 (1989) 268-272
3. Beresford L., Orange O., Bell E.B., and Miyan J.A. Nerve fibres are required to evoke a contact sensitivity response in mice. Immunology 111 (2004) 118-125
4. Bost K.L. Tachykinin-mediated modulation of the immune response. Front. Biosci. 9 (2004) 3331-3332
5. Bradesi S., Eutamene H., Theodorou V., Fioramonti J., and Bueno L. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sci. 68 (2001) 1047-1056
6. Dannenberg A.M. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology 191 (1994) 461-473
7. Duffy R.A. Potential therapeutic targets for neurokinin-1 receptor antagonists. Expert. Opin. Emerg. Drugs 9 (2004) 9-21
8. Elliott J.C., Picker M.J., Nelson C.J., Carrigan K.A., and Lysle D.T. Sex differences in opioid induced enhancement of contact hypersensitivity. J. Invest. Dermatol. 121 (2003) 1053-1059
9. Elliott J.C., Picker M.J., Sparrow A.J., and Lysle D.T. Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats. Psychopharmacology (Berlin) 185 (2006) 66-75
10. Enk A.H., and Katz S.I. Contact sensitivity as a model for T-cell activation in skin. J. Invest. Dermatol. 105 (1995) 80S-83S
11. Erin N., Ersoy Y., Ercan F., Akici A., and Oktay S. NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats. Clin. Exp. Dermatol. 29 (2004) 644-648
12. Gutwald J., Goebeler M., and Sorg C. Neuropeptides enhance irritant and allergic contact dermatitis. J. Invest. Dermatol. 96 (1991) 695-698
13. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol.a 30 (1998) 5-11
14. Kanda N., and Watanabe S. Substance P enhances the production of interferon-induced protein of 10 kDa by human keratinocytes in synergy with interferon-gamma. J. Invest. Dermatol. 119 (2002) 1290-1297
15. Kirk R.E. Experimental Design: Procedures for the Behavioral Sciences. 2nd ed. (1982), Wadsworth, Belmont, CA
16. Levine J.D., Moskowitz M.A., and Basbaum A.I. The contribution of neurogenic inflammation in experimental arthritis. J. Immunol. 135 (1985) 843s-847s
17. Li Y., Tian S., Douglas S.D., and Ho W.Z. Morphine up-regulates expression of substance P and its receptor in human blood mononuclear phagocytes and lymphocytes. Cell. Immunol. 205 (2000) 120-127
18. Mazelin L., Theodorou V., More J., Emonds-Alt X., Fioramonti J., and Bueno L. Comparative effects of nonpeptide tachykinin receptor antagonists on experimental gut inflammation in rats and guinea-pigs. Life Sci. 63 (1998) 293-304
19. Nelson C.J., and Lysle D.T. Involvement of substance P and central opioid receptors in morphine modulation of the CHS response. J. Neuroimmunol. 115 (2001) 101-110
20. Nelson C.J., and Lysle D.T. Morphine modulation of the contact hypersensitivity response: characterization of immunological changes. Clin. Immunol. 98 (2001) 370-377
21. Nelson C.J., How T., and Lysle D.T. Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase. Clin. Immunol. 93 (1999) 176-183
22. Pinto F.M., Armesto C.P., Magraner J., Trujillo M., Martin J.D., and Candenas M.L. Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment. Endocrinology 140 (1999) 2526-2532
23. Quinlan K.L., Song I.S., Naik S.M., Letran E.L., Olerud J.E., Bunnett N.W., Armstrong C.A., Caughman S.W., and Ansel J.C. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. J. Immunol. 162 (1999) 1656-1661
24. Rupniak N.M., Carlson E.J., Shepheard S., Bentley G., Williams A.R., Hill A., Swain C., Mills S.G., Di S.J., Kilburn R., Cascieri M.A., Kurtz M.M., Tsao K.L., Gould S.L., and Chicchi G.G. Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608. Neuropharmacology 45 (2003) 231-241
25. Scholzen T.E., Steinhoff M., Bonaccorsi P., Klein R., Amadesi S., Geppetti P., Lu B., Gerard N.P., Olerud J.E., Luger T.A., Bunnett N.W., Grady E.F., Armstrong C.A., and Ansel J.C. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J. Immunol. 166 (2001) 1285-1291
26. Scholzen T.E., Stander S., Riemann H., Brzoska T., and Luger T.A. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J. Immunol. 170 (2003) 3866-3873
27. Singh L.K., Pang X., Alexacos N., Letourneau R., and Theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav. Immun. 13 (1999) 225-239
28. Smith C.H., Barker J.N., Morris R.W., MacDonald D.M., and Lee T.H. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J. Immunol. 151 (1993) 3274-3282
29. Steinhoff M., Stander S., Seeliger S., Ansel J.C., Schmelz M., and Luger T. Modern aspects of cutaneous neurogenic inflammation. Arch. Dermatol. 139 (2003) 1479-1488
30. Tripp R.A., Moore D., Winter J., and Anderson L.J. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J. Virol. 74 (2000) 1614-1622
31. Villablanca A.C., and Hanley M.R. 17beta-estradiol stimulates substance P receptor gene expression. Mol. Cell. Endocrinol. 135 (1997) 109-117
32. Yang X. Distinct function of Th1 and Th2 type delayed type hypersensitivity: protective and pathological reactions to chlamydial infection. Microsc. Res. Tech. 53 (2001) 273-277